OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14822252

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to new triazolyl purine derivatives of formula (I), processes for their preparation, and to pharmaceutical compositions containing them for the treatment of neurological disorders or cerebral ischaemia for which inhibition of adenosine A2A receptor will result at improving the health state of a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S P A00144 ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CABRI, Walter Rozzano (MI), IT 98 224
MINETTI, Patrizia Rome, IT 18 160
PIERSANTI, Giovanni Urbino (PU), IT 3 3
TARZIA, Giorgio Petriano (PU), IT 36 172

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation